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This article presents a review, based on a qualitative study, of pharmaceutical orientation in the 
management of minor illness. Action research methodology was used by a group of faculty members 
responsible for the community pharmacy internship and by postgraduates in clinical pharmacy, to carry 
out the study with the objective to present a standard service for this kind of procedure. The interaction 
with the individual starts with a welcoming reception, at which point the pharmacist should be receptive 
and show empathy. Subsequently, data from the history of the patient are collected to obtain relevant 
information. Based on this information, the pharmacist must develop a line of clinical reasoning and 
make a decision, taking the context of the patient into account. After this analysis, the most appropriate 
intervention is performed. This intervention could indicate the need for referral to another health 
professional, the use of a non-pharmacological therapy or the provision of sound advice on medicines 
available without prescription. The next step is monitoring the patient in order to identify the effectiveness 
and safety of treatment. The standardization process of pharmaceutical attendance in the management 
of minor disorders contributes to the rational use of medicines.
Uniterms: Self-medication. Community pharmacy. Drugs/rational use. Pharmaceutical orientation. 
Responsible self-medication. Minor illness. 
A reflexão apresentada neste artigo representa um estudo de abordagem qualitativa baseada na pesquisa-
ação da prática do atendimento farmacêutico no manejo de transtornos menores, realizada pelo grupo 
de professores do Estágio em Farmácia Comunitária e por farmacêuticos pós-graduados em Farmácia 
Clínica, com o objetivo de realizar uma proposta de atendimento padrão para este tipo de procedimento. 
A interação com o indivíduo é iniciada pelo acolhimento, momento no qual o farmacêutico deve ser 
receptivo e empático. A seguir, se executa a coleta de dados sobre a história do paciente, para obtenção 
de informações relevantes. Com base nas informações, o farmacêutico deve desenvolver um raciocínio 
clínico e tomar uma decisão, levando em consideração o contexto do paciente. Após esta análise é realizada 
a intervenção mais adequada ou o conjunto dessas que podem ser: procurar outro profissional de saúde, 
utilizar uma terapia não-farmacológica ou auxiliar na escolha de um medicamento de venda livre. O 
próximo passo é o acompanhamento do paciente com vistas a identificar a efetividade e segurança do 
tratamento. A padronização do processo de atendimento farmacêutico no manejo de transtornos menores, 
contribui para o uso racional de medicamentos.
Unitermos: Automedicação. Farmácia comunitária. Medicamentos/uso racional. Orientação farmacêutica. 
Automedicação responsável. Transtornos menores.
INTRODUCTION
The World Health Organization (WHO, 1998) and 
the International Pharmaceutical Federation (FIP, 1999) 
define self-medication as a practice by which an individual 
selects and uses medicines to treat symptoms or minor 
health problems, recognized as such by themselves. When 
done correctly, self-medication can benefit the individual’s 
health and is recognized by the WHO as part of self-care 
(WHO, 1998; WSMI, 2006a).
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Self-care is understood as what a person does by 
themselves to establish and maintain health, preventing 
and dealing with disease. This concept includes health, 
nutrition, lifestyle, socioeconomic and environmental 
factors, as well as self-medication (WHO, 1998; WSMI, 
2006a). Lately, individuals have taken greater personal 
responsibility for their health and are seeking more infor-
mation to make appropriate decisions about their treatment 
(FIP, 1999) either from reliable sources or from other 
questionable sources, such as websites (Barros, 2004).
In the treatment of minor illness, when problems are 
self-limited, self-care can be used. According to Winfield 
and Richards (1998), the criteria for considering health 
problems as a minor illness include having limited dura-
tion and being perceived as non-threatening to the patient.
In the international arena, there is a change in the 
treatment of these minor ailments through using self-care, 
encouraged by drug policies in countries around world. 
For government institutions, this can reduce costs while 
allowing health professionals to focus on more serious 
health problems (Volmer; Lilja; Hamilton, 2007). When 
this occurs, and when the management of these ailments is 
accomplished through drugs or medicinal plants, it beco-
mes self-medication. In this case, pharmacist orientation is 
important to guarantee a responsible self-medication plan.
It is estimated that in the United States, some 100 to 
150 million general practitioner consultations a year are 
related to conditions that could be self-treated. Whittington 
et al., (2001) conducted a study in which patients with 
minor disorders who sought a general practitioner were 
sent to pharmacists in registered community pharmacies. 
The results indicated that these pharmacists were able to 
successfully resolve a series of minor disorders, through 
a specifically defined form, resulting in a small number of 
patients having to return to the doctor.
In recent decades, the pharmacist’s role has been 
changing, being not only as drug dispenser, but acting as 
part of a multidisciplinary team involved in health care 
(WHO, 1998; Petty, 2003). It is important to emphasize 
the accessibility of consumers to the pharmacists, those 
working in either the public sector or in private pharma-
cies. Confirming such responsibility, Loyola Filho, et al, 
(2002) found significant association between pharmacist 
consultation and the use of non-prescribed drugs in Bam-
buí, Minas Gerais. 
Each year, millions of new products are launched 
in the drug market as over-the-counter (OTC) medicines, 
and community pharmacists are in an excellent position 
to provide correct information on the use of these drugs 
(Blenkinsopp, Paxton, 2005; Covington, 2006). Even 
though a prescription for the sale of OTCs is not required, 
they can be harmful, creating risks to patients when used in 
incorrectly. It is noteworthy that in Brazil, 35% of medici-
nes are marketed through self-medication (Aquino, 2008). 
While self-medication can produce good results and 
be a convenient practice for the patient (WSMI, 2006a; 
WSMI, 2006b; Covington, 2006), it can also cause serious 
health risks such as bacterial resistance, dependence, di-
gestive bleeding, hypersensitivity reactions, drug withdra-
wal symptoms, as well as increase the risk of neoplasia. 
In addition to these risks, it should be emphasized that 
the momentary relief of symptoms may actually mask the 
underlying disease (Vilarino et al., 1998; Aquino, 2008). 
The indiscriminate use of medicines can also incre-
ase the chances of intoxication, according to the National 
System of Toxic-Pharmacological Information (Sistema 
Nacional de Informações Tóxico-Farmacológicas - SINI-
TOX); medicines are the second-most frequent causative 
agents of intoxication in humans. They are responsible for 
26% of intoxication recorded in the country in 2005, where 
590 cases were a result of self-medication (Bochner, 2005).
In a self-care context when there is need for medi-
cines, the clinical pharmacist has a key role in assisting to 
identify the best intervention. This may include referral to 
another health professional, suggesting a different non-phar-
macological therapy, helping to choose an OTC medicine 
that is safe and effective, and ensuring that it is used correc-
tly (WHO, 1998, Wazaify et al., 2005; Covington, 2006).
Therefore, responsible self-medication promotes the 
rational use of medicines. According to the World Health 
Organization, the rational use of medicines is regarded as 
a situation in which the patient receives the appropriate 
medicine for their clinical need, at a correct dosage, for 
an appropriate period of time, and at a lower cost to the-
mselves and the community (WHO, 2002).
However, to ensure responsible self-medication, it 
is necessary for pharmaceutical establishments to have a 
standardized sequence of actions for a particular patient 
care procedure in order to manage care adequately. An ini-
tiative in this direction was taken by the European Union 
which has developed protocols for minor disorders that 
help in the interview and decision making stages (Cordero 
et al., 2001).
The objective of this article is to examine the phar-
maceutical attendance process that requires guidance in 
managing minor disorders recognized as such by patients 
or their caregivers at pharmaceutical establishments.
METHODS
The review presented in this article follows a quali-
tative approach based upon action research methodology 
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(Minayo, 2004) of the pharmaceutical care practice in the 
management of minor disorders, and was performed by a 
group of faculty members responsible for the community 
pharmacy internship, and by postgraduates in clinical 
pharmacy.
This review arose from the need to establish a care 
standard for the process of responsible self-medication at 
the University Pharmacy School.
The results presented in this paper are represented 
in a flowchart showing the process of pharmaceutical 
attendance in the management of minor disorders. For 
each stage, the necessary guidelines for decision making 
are discussed, based on the literature whenever possible.
It is important to note that the authors of this article 
adopted the word user to represent the person asking 
the pharmacy to manage a health problem and the word 
patient to represent individuals having a health problem. 
This distinction is important because user and patient have 
different connotations.
RESULTS AND DISCUSSION
When the clinical pharmacist is available to assist 
the process of responsible self-medication, it is important 
to emphasize that interventions should only occur in situ-
ations when a minor disorder is identified. 
The term model of care is used to present various 
steps that should constitute the process of responsible 
self-medication. It is at the discretion of the professional 
to determine the sequence of steps needed using a style 
and manner of questioning consistent with the situation 
that that fosters spontaneous consultation. This allows 
the clinical pharmacist to develop their own method of 
questioning for data collection in which he can encourage 
conversation with the patient. Blenkinsopp and Paxton 
(2005) also reinforce the importance of allowing flexibility 
and adaptation of the model to the professional’s individu-
al characteristics. It must be emphasized that this should 
be performed only by pharmacists, as it is their exclusive 
responsibility while on duty in a pharmacy.
In the process of self-medication in pharmaceutical 
care, it is important to identify the pharmacy user, whether 
they represent another customer about whom they are 
unable to provide more detailed information, or if they 
are responsible for the patient (caregiver), or they are 
themselves the patient.
Welcoming reception: the beginning of interaction
The interaction can be initiated by either the pharma-
cist or the user. In the welcome reception, communication 
is essential in order to develop a therapeutic relationship 
(Berardi et al., 2000; Cipolle, Strand, Morley, 2004). In 
this context, the pharmacist should show empathy, convey 
confidence, and be receptive to create conditions conduci-
ve for conducting the interview and collecting patient data 
(as described by Galato et al., 2008).
If the pharmacist is not acquainted with the user, it 
is important to introduce themselves personally by saying, 
“Hello, are you doing? I am the duty pharmacist here. How 
may I help you?” Similarly, the user should be addressed 
by his or her name (Berger, 2005).
It is essential to identify the person with the com-
plaint that led to pharmaceutical care being sought. This 
point is important because it will dictate how the entire 
service is rendered, as follows: 
Situation in which the user is the patient or 
caregiver
Data collection on the history of the patient
In this situation, the pharmacist is able to explore the 
information needed to make a decision on the intervention. 
For this to occur, it is essential that the pharmacist has the 
appropriate communication skills to collect information, 
as well as knowledge of minor disorders and therapeutic 
alternatives. Without this ability and knowledge, it is 
impossible to collect data adequately and consequently 
responsible self-medication cannot occur. This requires 
the professional to be prepared through continuous study 
and professional development.
Initially, data should be collected on the patient’s 
profile, such as age, gender (usually obtained by visual 
observation), current diseases, medications, and other pro-
ducts in use, as well as medicinal and food supplements, 
or herbal teas. It is also important to learn if the patient 
has any allergies as well as gather information on family 
disease history (Swartz, 1992). 
With regard to the initial complaint that led to se-
eking the pharmacy establishment, it is important to ascer-
tain information such as: when did it start, how often does 
this occur, with what severity, what has already been done 
to address it, what was the result of previous treatment, 
is this a recurrent problem, and how was the problem re-
solved in that situation? During this phase it is important 
that the pharmacist focuses on both the patient’s verbal 
and nonverbal communication. Special attention should be 
given to the use of open questions, as exemplified above, 
in order to avoid inducing implied responses. The use ne-
gative words should be avoided, especially by questioning 
“why”, since it could suggest that the pharmacist would 
prefer responses confirming the negative, or disapprove 
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of the focus of the question (Swartz, 1992). Questioning 
skills should be trained, so as not to ask for unnecessary 
information or that the patient has already provided. 
When the data collection generates user mistrust or 
discomfort, the pharmacist must explain the importance 
of the information related to the symptoms and how it 
contributes to the best selection of treatment alternatives, 
and that any information collected is strictly confidential 
(Conselho Federal de Farmácia, 2004). 
Besides the previously emphasized communication 
skills, it is essential to have accurate knowledge of minor 
disorders and alternative therapies in order to collect infor-
mation adequately; deficiencies in communication skills 
or lack of knowledge make the process of data collection 
inefficient, impairing the professional’s ability to develop 
responsible self-medication.
Pharmacists can perform their function properly when 
they are fully capable of distinguishing between minor and 
major disorders (Blenkinsopp, Paxton, 2005). This requires 
careful observation and adequate questioning to identify 
the symptoms reported by patients, which may have a 
potentially serious cause. In this case, the patient should be 
referred to a health specialist (Winfield, Richards, 1998).
Data compilation and pharmaceutical intervention
Once the information is collected, the pharmacist 
should then be able to develop a clinical analysis regarding 
the patient’s ailment. If in doubt, further inquiry should 
be made before reaching a decision. However, in most 
situations, the pharmacist is constantly assessing their plan 
of action as the inquiry proceeds.
After examining the patient’s condition, the pharma-
cist may determine that it is not a minor disorder, or that it 
is a special situation. In this case, the patient or caregiver 
should be advised to seek appropriate professional help, 
usually from a physician.
In the previous situation, pharmaceutical interven-
tion can target the temporarily relief of symptoms, or 
prevent further complications. Examples of special situ-
ations include the elderly, children, pregnant women, pa-
tients with chronic diseases, poly-medicated individuals, 
and recently hospitalized patients. The physician should 
always be consulted, either in person (Berardi et al., 2000) 
or at least by being notified as soon as possible about the 
intervention performed. However, it is important to note 
that some studies (Cascaes et al., 2008; Pereira et al., 2007; 
Osorio de Castro; Paumgartten; Silver, 2004) have shown 
that, even in special cases, self-medication is a common 
practice that needs to be streamlined. 
However, there are often cases in which the subjects 
have received prior advice from their doctor to self-me-
dicate in certain situations; this is common, especially in 
the areas of pediatrics and obstetrics. In these situations, 
it is the pharmacist’s responsibility to assess the patient’s 
complaint and provide the medication (previously selected 
by the prescriber) only when they are satisfied that the 
signs and symptoms are characteristic of minor disorders. 
The guidelines for monitoring should be streng-
thened, emphasizing that patients should be referred to 
a doctor in cases of persistent or worsening symptoms. 
Winfield and Richards (1998) explain that an initial 
doctor’s consultation is required for correct diagnosis and 
proper treatment, as well as subsequent monitoring of the 
individual. Accordingly, the doctor recommends the same 
treatment to control similar symptoms identified by the 
patient, such as an allergy, for example.
When a minor disorder occurs in a given patient not 
classified as a special case, such as those mentioned earlier, 
the use of an OTC medicine or other non-pharmacological 
therapeutic approach can be suggested. The method 
adopted should be explained to the patient by referring 
to the main complaint and presenting the possibilities of 
management.
To address the main complaint, the symptoms 
described by patients that help identify the problem as a 
minor disorder should be reviewed. This would provide 
the patient with the opportunity to clarify the signs and 
symptoms being reported. At the same time, it allows phar-
macists to better understand the data they have collected, 
as well as patients to understand their current health status 
and needs for treatment. In other words, those symptoms 
that can be alleviated are identified, although the disorder 
may not immediately be resolved, a typical characteristic 
of minor health problems. Subsequently, treatment possi-
bilities are presented to the patient, who is also given an 
explanation on the function of each procedure in order to 
decide which drugs will be selected. In situations where 
the pharmacist has just a single treatment option available 
at the pharmacy, then the professional should adopt the 
most appropriate treatment for that situation by explaining 
which drugs are available. Another option is to suggest that 
the patient wait for the pharmacy to purchase a different 
product that could also be used (a common practice that 
has been facilitated by the present rapid medicine distri-
bution system). 
There are also situations in which patients or caregi-
vers intend to use an alternative therapy which they have 
used previously, or intend to purchase a particular product 
for the management of their symptoms. In these situations, 
the pharmacist must assess the patients’ selection to see 
whether it is appropriate. If it is not, the pharmacist should 
present and explain the different options available.
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In situations where an alternative therapy is selected 
(in this case, always represented by OTC medicines), the 
pharmacist should:
·	 Draw up a plan to be followed by the patient, outli-
ning the objectives to be achieved (Cipolle; Strand; 
Morley, 2006).
·	 Provide information on dosage, the most common 
adverse reactions, and expected effect and interac-
tions, while paying attention not to overburden the 
user with too much information.
·	 Highlight or write down the most important gui-
delines for the patient to remember; in this case, 
pictograms can also be used (Galato et al., 2006).
·	 Make sure that the patient understands the instruc-
tions, related to both the use and the expected effect. 
It is always important to remember that the pharma-
cological management adopted may not be the only one 
available. As previously noted, minor health disorders are 
self-limited, therefore they respond well to non-pharma-
cological management which is usually upon adoption of 
simple care, or even a change in lifestyle.
The pharmacist must inform the patient how the 
minor disorder is expected to evolve, and if it does not 
improve, they should reinforce the need to return to the 
pharmacy or refer the patient to a doctor for professional 
care. Finally, the patient must understand the need for 
pharmaceutical intervention monitoring, when appro-
priate.
Intervention monitoring and evaluation of results
In intervention monitoring, it is vital that the patient 
understands the expected evolution of the minor disorder 
to ensure that selected treatment is effective. For this to 
occur, the pharmacist should explain to the patient, for 
example, “your flu will get better in a week; if it does not, 
consult your doctor. If new symptoms arise, you can che-
ck back with me as I have already seen you (or you may 
consult another pharmacist) to re-evaluate the situation.”
Moreover, the patient must be aware of the warning 
signs and symptoms that may appear. In case of worsening, 
they must be instructed to consult a doctor. The patient 
should be informed of how this may manifest, for example: 
“in case of fever, an increase in temperature can indicate 
a worsening condition”. 
Intervention monitoring should be encouraged in all 
situations, requiring the person to return to the pharmacy 
after a predetermined time to make sure that the selected 
treatment was appropriate, and whether or not a new 
assessment is necessary. If the treatment was found to be 
ineffective or unsafe, the causes should be evaluated by 
reexamining the patient to determine if the case is really a 
minor disorder, and if the patient should consult another 
health professional.
In case of any adverse reaction, the pharmacist must 
inform the National Sanitary Surveillance Agency (Agen-
cia Nacional de Vigilância Sanitária – ANVISA) through 
the appropriate electronic form (ANVISA, 2008). Both 
the patient’s data and the pharmacist’s decision should 
be recorded on a form and stored in the pharmacy. The 
result(s) obtained can also be recorded, when possible, in 
the event the patient returns to the pharmacy. This allows 
the pharmacist to constantly evaluate the quality of their 
interventions related to responsible self-medication. This 
contact does not necessarily need to be done in person, sin-
ce the user and/or caregiver can be reached by telephone.
The practice of recording the pharmacist’s actions is 
similar to that in the process of pharmaceutical care, where 
the pharmacist takes joint responsibility with the patient 
for the pharmacotherapy in order to prevent, identify 
and solve problems related to medications by assessing 
their necessity, effectiveness and safety (Hepler, Strand, 
1990; Cipolle, Strand, Morley, 2004). Therefore, it must 
be emphasized that self-medication can take place during 
the process of pharmaceutical care, or constitute entry of 
new patients to this service.
Situation in which the user is neither the patient 
nor the caregiver
This is a very complex situation, though very com-
mon in pharmaceutical establishments, because in most 
cases it is not possible to collect data on the patient’s his-
tory, while often the user arrives at the pharmacy with the 
task of buying a particular product. In this case, informa-
tion should be analyzed as far as possible and provide only 
products that are exempt from prescription and that have 
no possibility of conflicting with the profile of the patient 
identified in the situation.
In case of doubt or lack of important information, the 
pharmacist should try to contact the patient by telephone, 
for example, to clarify points deemed critical to health 
care delivery.
If doubts cannot be resolved or if there are identified 
incompatibilities, the product should not be dispensed.
Regardless of the position taken in this situation, 
the pharmacist must provide information (advice) on the 
symptoms presented by patients, even when the service 
was completed without delivery of a product, so that the 
user or the person who went to purchase the product, 
understands the reasons why the pharmacist has made 
this decision. Furthermore, the professional must always 
provide information for further contact.
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1. Elderly, children, chronically ill, poly-medicated, and recently hospitalized.
2. To dispense, providing instruction on indication, expected effect, duration of treatment (and other information such as interactions and adverse 
effects must be presented when appropriate).
FIGURE 1 – Process of attendance in the management of minor illness.
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Responsible self-medication and pharmaceutical 
commerce
The pharmacy is a facility that combines the pro-
duction and use of medicines. In recent years, the com-
munity pharmacy has been regarded less as a national 
health service and more as a commercial establishment 
(Barros, 1997). Thus, the influence of commerce through 
the advertisement of medicines (Barros, 2004), subsidy 
policies, and commission on sales can be an obstacle to 
the promotion of rational use of medicines.
However, responsible self-medication, when put 
into practice, requires the pharmacy to have a health esta-
blishment profile. In this context, the pharmacist values the 
patients care while minimizing conflict with commercial 
interests. It is therefore important to emphasize that the gre-
atest return for the pharmaceutical establishment should be 
the sale of products related to prescribed medicines, and the 
provision of services (such as measurement of blood pres-
sure and injection administration). In addition, a pharmacy 
designed as a health establishment should comply with 
regulations, provide the physical infrastructure, services and 
above all, the appropriate professional skills and attitudes 
for those who work there (Galato, Angeloni, 2009).
It is important to note that self-medication cannot 
simply be denied and ignored by pharmacists. Criteria 
should be established to manage this in a responsible 
manner, as recommended by respected organizations 
such as the World Health Organization (WHO), the In-
ternational Federation of Pharmaceutical Industry, and 
the World Self-Medication Industry (WSMI), as well as 
the Federal Council of Pharmacy (Conselho Federal de 
Farmácia, 2001).
CONCLUSION
The review presented in this article highlights the 
importance of standardizing patient care with minor 
disorders. In addition to pursuing the establishment of a 
model of care, it is necessary for clinical pharmacists to 
constantly engage in the process of self-evaluation and to 
seek improvement and new knowledge that can provide 
quality service. However, it should be emphasized that this 
model is not intended to advocate self-medication, but to 
provide a process of responsible self-medication in order 
to promote the rational use of medicines.
Furthermore, the ability to communicate effectively 
is essential to ensure service quality. In this sense, the 
internship performed during the education stage helps 
students develop this skill, which will be very useful in 
their professional career.
In addition to effective communication, the phar-
macist should have knowledge about minor disorders 
and other health issues, as well as on medicines (either 
nonprescription drugs that can be adopted in a self-
medication regimen, or those for continuous use by pa-
tients). Moreover, knowledge of other strategies related 
to self-medication is of fundamental importance in the 
management of health problems; particularly since the 
medicalization of society cannot be ignored by health 
professionals (Barros, 2004).
The pharmacist should work in co-operation with the 
health team, performing the role of a professional with a 
focus on patient health and on using medicines as a tool. 
As part of this review, it is important to emphasize that 
quality care can only exist when a responsible partnership 
between the patient or caregiver and the pharmacist is in 
place. Therefore, pharmacists’ role in society constitutes 
an important contribution to the rational use of medicines, 
particularly in situations characterized as self-medication.
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